HOME >> MEDICINE >> NEWS
Accountability in Clinical Research: Balancing Risk and Benefit

INDIANAPOLIS - Human participation in research has surged in recent years as scientists seek causes and cures of myriad diseases. Accompanying the increase too has been greater public concern for patient safety and scrutiny of complex ethical, legal and regulatory issues.

Such issues will be tackled April 24-26 by Indiana University School of Medicine physicians and researchers and other prominent scientists at a national forum at the University Place Conference Center on the Indiana University-Purdue University Indianapolis campus. Accountability in Clinical Research: Balancing Risk and Benefit, sponsored by the National Patient Safety Foundation, will examine the management, conduct, funding and accountability of research involving human subjects.

Sharon M. Moe, M.D., IU School of Medicine's assistant dean for research support, will lead talks in a session about the role of oversight in assuring patient safety in clinical research. Eric M. Meslin, Ph.D., director of the IU Center for Bioethics, takes the lead in discussing the quality and content of information supplied to research patients about their roles and risks Media interest in biomedical research also has sharply increased, often focusing on controversial incidents involving health outcomes of patients. David W. Crabb, M.D., chairman of the School's Department of Medicine, and members of Indianapolis' news media will discuss and analyze real and hypothetical situations and responses to media coverage.

"This conference opens the door to continued dialogue about patient safety issues in clinical research settings," says Carol A. Ley, M.D., Ph.D., chair of NPSF's board of directors.

"The insight and experiences shared at this conference will be invaluable to health-care professionals, researchers, consumers and government entities - all essential in moving patient safety messages to a new level."

Today's health care consumers, payers, providers and profess
'"/>

Contact: Joe Stuteville
jstutevi@iupui.edu
317-274-7722
Indiana University
10-Apr-2002


Page: 1 2

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology:
Cached News: